Literature DB >> 20872994

The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.

Joel Pinczewski1, Andrzej Slominski.   

Abstract

Hormonally active vitamin D3, 1,25-(OH)2D3, is believed to have a role in the prevention of cancer formation and in limiting the aggressiveness of cancers that do arise. Therefore,much interest is presently being focused on 1,25-(OH)2D3 and its analogues as potential treatments for various cancers including melanoma. This article discusses the evidence in favour of a role for 1,25-(OH)2D3 in protection against the progression of melanocytic lesions and also summarizes the mechanisms by which 1,25-(OH)2D3 may act to protect against melanoma development and progression.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20872994      PMCID： PMC2947742          DOI： 10.1111/j.1600-0625.2010.01169.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


  100 in total

1.  Re: Sun exposure and mortality from melanoma.

Authors:  Robert P Dellavalle; Robert D Dellavalle; Kathryn R Johnson
Journal:  J Natl Cancer Inst       Date:  2005-08-03       Impact factor: 13.506

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.

Authors:  Jörg Reichrath; Martin Rech; Maryam Moeini; Eckart Meese; Wolfgang Tilgen; Markus Seifert
Journal:  Cancer Biol Ther       Date:  2007-01       Impact factor: 4.742

Review 4.  Vitamin D and genomic stability.

Authors:  M Chatterjee
Journal:  Mutat Res       Date:  2001-04-18       Impact factor: 2.433

Review 5.  Neuroendocrinology of the skin.

Authors:  A Slominski; J Wortsman
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

6.  Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues.

Authors:  U Berger; P Wilson; R A McClelland; K Colston; M R Haussler; J W Pike; R C Coombes
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.

Authors:  Andrzej Slominski; Jordan Zjawiony; Jacobo Wortsman; Igor Semak; Jeremy Stewart; Alexander Pisarchik; Trevor Sweatman; Josep Marcos; Chuck Dunbar; Robert C Tuckey
Journal:  Eur J Biochem       Date:  2004-11

Review 8.  Role of the vitamin D3 pathway in healthy and diseased skin--facts, contradictions and hypotheses.

Authors:  Bodo Lehmann
Journal:  Exp Dermatol       Date:  2009-02       Impact factor: 3.960

9.  Topical calcitriol protects from UV-induced genetic damage but suppresses cutaneous immunity in humans.

Authors:  Diona L Damian; Young Jin Kim; Katie M Dixon; Gary M Halliday; Arash Javeri; Rebecca S Mason
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

10.  Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study.

Authors:  J M Elwood; R P Gallagher; G B Hill; J C Pearson
Journal:  Int J Cancer       Date:  1985-04-15       Impact factor: 7.396
View more
  9 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 2.  The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Wei Li; Ae-Kyung Yi; Arnold Postlethwaite; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-28       Impact factor: 4.292

3.  Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Zorica Janjetovic; Andrzej T Slominski
Journal:  Hum Pathol       Date:  2012-09-17       Impact factor: 3.466

4.  Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes.

Authors:  Andrzej T Slominski; Zorica Janjetovic; Tae-Kang Kim; Adam C Wright; Laura N Grese; Samuel J Riney; Minh N Nguyen; Robert C Tuckey
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

Review 5.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Cezary Skobowiat; Blazej Zbytek; Radomir M Slominski; Jeffery D Steketee
Journal:  Adv Anat Embryol Cell Biol       Date:  2012       Impact factor: 1.231

6.  Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.

Authors:  Edith K Y Tang; Jianjun Chen; Zorica Janjetovic; Elaine W Tieu; Andrzej T Slominski; Wei Li; Robert C Tuckey
Journal:  Drug Metab Dispos       Date:  2013-03-01       Impact factor: 3.922

7.  Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity.

Authors:  Elaine W Tieu; Edith K Y Tang; Jianjun Chen; Wei Li; Minh N Nguyen; Zorica Janjetovic; Andrzej Slominski; Robert C Tuckey
Journal:  Biochem Pharmacol       Date:  2012-10-05       Impact factor: 5.858

8.  High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives.

Authors:  Z Janjetovic; A A Brozyna; R C Tuckey; T-K Kim; M N Nguyen; W Jozwicki; S R Pfeffer; L M Pfeffer; A T Slominski
Journal:  Br J Cancer       Date:  2011-11-17       Impact factor: 7.640

Review 9.  Current Molecular Markers of Melanoma and Treatment Targets.

Authors:  Kevin Yang; Allen S W Oak; Radomir M Slominski; Anna A Brożyna; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.